Related Experiment Video

Updated: Aug 8, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells

L Bai1, L Wei, J Wang

  • 1Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|May 10, 2006
PubMed

Insights

Short hairpin RNA (shRNA) targeting HPV16 E6 oncogene effectively suppressed cervical cancer cells. This approach shows potential for treating persistent human papillomavirus (HPV) infections and HPV-positive cervical carcinoma.

Area of Science:

  • Molecular Biology
  • Oncology
  • Virology

Background:

  • Cervical carcinomas frequently express high-risk human papillomavirus (HPV) E6 and E7 oncogenes.
  • Small interfering RNA (siRNA) technology offers sequence-specific gene expression inhibition in mammalian cells.

Purpose of the Study:

  • To identify the most effective short hairpin RNA (shRNA) for inhibiting HPV16 E6 mRNA.
  • To investigate the long-term effects of HPV16 E6 shRNA on cervical carcinoma cells.

Main Methods:

  • Stable transfection of SiHa cells with four shRNA expression vectors (E6A-D).
  • Quantification of HPV16 E6 mRNA levels and assessment of protein accumulation (p53, p21, pRb).
  • Evaluation of cell proliferation, colony formation, tumorigenicity, and invasion assays in transfected cells.

Main Results:

  • HPV16 E6A shRNA demonstrated the highest efficiency, reducing HPV16 E6 mRNA to 10% in SiHa cells.
  • E6A shRNA stably reduced HPV16 E6 and E7 gene expression for over 4 months.
  • Repression of E6/E7 led to p53, p21, and hypophosphorylated pRb accumulation, suppressing proliferation, colony formation, tumorigenicity, and invasion.

Conclusions:

  • shRNA expression vectors represent a potential therapeutic strategy for persistent HPV infections.
  • This approach may be effective in treating HPV-positive cervical carcinoma by targeting viral oncogenes.

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells09:20

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells

Published on: July 23, 2010

Related Concept Videos

Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...